HomeInsightsPE

Sakar Healthcare Ltd P/E Ratio

Sakar Healthcare Ltd P/E Ratio

download
stocks purchased

₹ 2.7 Cr

Volume transacted

stocks purchased

76.7 K

stocks traded

Last Updated time: 18 Jul 15:30 PM

Image

Sakar Healthcare Ltd

NSE: SAKAR

PE

62.1

Last updated : 18 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Sakar Healthcare Ltd is 62.1 as of 18 Jul 15:30 PM .a1#The P/E Ratio of Sakar Healthcare Ltd changed from 7.8 on March 2020 to 29.9 on March 2023 . This represents a CAGR of 39.92% over 4 years. a1#The Latest Trading Price of Sakar Healthcare Ltd is ₹ 356.1 as of 18 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 24.5. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 36.7. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.5. In 2024a1#The Market Cap of Sakar Healthcare Ltd changed from ₹ 74.73 crore on March 2020 to ₹ 381.94 crore on March 2023 . This represents a CAGR of 50.36% over 4 years. a1#The Revenue of Sakar Healthcare Ltd changed from ₹ 28.94 crore to ₹ 43.83 crore over 8 quarters. This represents a CAGR of 23.07% a1#The EBITDA of Sakar Healthcare Ltd changed from ₹ 8.36 crore to ₹ 11.74 crore over 8 quarters. This represents a CAGR of 18.50% a1#The Net Pr of Sakar Healthcare Ltd changed from ₹ 2.88 crore to ₹ 3.12 crore over 8 quarters. This represents a CAGR of 4.08% a1#The Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Sakar Healthcare Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Sakar Healthcare Ltd

Period
Mar '207.8
Mar '2116.5
Mar '2215.2
Mar '2329.9
Image

Sakar Healthcare Ltd

NSE: SAKAR

PRICE

356.1

22.45 (6.73%)

stock direction

Last updated : 18 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Sakar Healthcare Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value of Sakar Healthcare Ltd

Market Value

726

Asset Value

60

11.1 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Sakar Healthcare Ltd62725
Sun Pharmaceuticals Industries Ltd37378,915
Cipla Ltd28122,044
Divis Laboratories Ltd75121,185
Zydus Lifesciences Ltd30119,224
Dr Reddys Laboratories Ltd20110,827

Key Valuation Metric of Sakar Healthcare Ltd

Earnings

11 Cr

62.1 X

PE Ratio

Market Cap

₹725.69Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

11 Cr

62.1 X

PE Ratio

Market Cap

₹725.69Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Sakar Healthcare Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Sakar Healthcare Ltd

Period
Mar '2075
Mar '21177
Mar '22231
Mar '23382

* All values are a in crore

×

Historical Revenue of Sakar Healthcare Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Sakar Healthcare Ltd

Period
Jun '2229
Sep '2231
Dec '2235
Mar '2342
Jun '2341
Sep '2335
Dec '2337
Mar '2444

* All values are a in crore

×

Historical EBITDA of Sakar Healthcare Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Sakar Healthcare Ltd

Period
Jun '228
Sep '229
Dec '2211
Mar '2310
Jun '2311
Sep '2310
Dec '239
Mar '2412

* All values are a in crore

×

Historical Net Profit of Sakar Healthcare Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Sakar Healthcare Ltd

Period
Jun '223
Sep '222
Dec '224
Mar '234
Jun '233
Sep '234
Dec '232
Mar '243

* All values are a in crore

×

Historical Dividend Payout of Sakar Healthcare Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Sakar Healthcare Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Sakar Healthcare Ltd

About Sakar Healthcare Ltd

    Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc. The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote d'ivoire. In 2005, the Company started commercial production for Plant - 1 which was established for production of Liquid Orals; in 2007, it started exporting its products overseas; started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet in 2008. Further, it started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials. In 2012, it started commercial production for Plant - 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation. In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022, the Company started commercialization with Oncology product post receiving WHO GMP certification.

Sakar Healthcare Ltd News Hub

News

Sakar Healthcare to convene board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 21 May 20...

Read more

15 May 202416:27

News

Sakar Healthcare soars after oncology unit receives EU GMP approval

Sakar Healthcare announced today that its oncology unit located in Bavla, Gujarat, has rec...

Read more

06 Mar 202412:19

News

Sakar Healthcare to conduct EGM

Sakar Healthcare announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

28 Nov 202314:10

News

Sakar Healthcare to conduct board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 21 Novemb...

Read more

17 Nov 202311:10

News

Sakar Healthcare announces board meeting date

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 6 Novembe...

Read more

02 Nov 202317:15

News

Sakar Healthcare to convene board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 14 August...

Read more

09 Aug 202314:14

Product Composition by Percentage (Revenue)

FAQs for PE of Sakar Healthcare Ltd

What is Sakar Healthcare Ltd current share price?

The current market price of Sakar Healthcare Ltd as of July 18, 2024 is ₹NaN.

What is Sakar Healthcare Ltd's market cap?

Sakar Healthcare Ltd's market capitalisation stood at ₹725 Cr as of July 18, 2024

What are Sakar Healthcare Ltd's total net assets?

According to Sakar Healthcare Ltd's most recent financial filings, the company's net assets total ₹59.8 Cr.

Is Sakar Healthcare Ltd making a profit or loss?

Sakar Healthcare Ltd's net Profit as of July 18, 2024 is close to ₹11 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199